Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 7.56 million. The enterprise value is 36.35 million.
| Market Cap | 7.56M |
| Enterprise Value | 36.35M |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 28.76 million shares outstanding. The number of shares has increased by 54.65% in one year.
| Current Share Class | 28.60M |
| Shares Outstanding | 28.76M |
| Shares Change (YoY) | +54.65% |
| Shares Change (QoQ) | +3.08% |
| Owned by Insiders (%) | 40.90% |
| Owned by Institutions (%) | 0.06% |
| Float | 16.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | -0.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.74 |
| EV / Sales | 2.35 |
| EV / EBITDA | 48.00 |
| EV / EBIT | 257.39 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21
| Current Ratio | 0.21 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | 35.77 |
| Debt / FCF | n/a |
| Interest Coverage | 0.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 1.51% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -0.78% |
| Weighted Average Cost of Capital (WACC) | 11.96% |
| Revenue Per Employee | 335,874 |
| Profits Per Employee | -102,105 |
| Employee Count | 46 |
| Asset Turnover | 2.65 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.96% in the last 52 weeks. The beta is 1.37, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -27.96% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 43.90 |
| Average Volume (20 Days) | 38,645 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.88 |
Income Statement
In the last 12 months, Biotricity had revenue of 15.45 million and -4.70 million in losses. Loss per share was -0.18.
| Revenue | 15.45M |
| Gross Profit | 12.53M |
| Operating Income | 141,213 |
| Pretax Income | -4.02M |
| Net Income | -4.70M |
| EBITDA | 147,166 |
| EBIT | 141,213 |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 1.43 million in cash and 27.09 million in debt, with a net cash position of -25.66 million or -0.89 per share.
| Cash & Cash Equivalents | 1.43M |
| Total Debt | 27.09M |
| Net Cash | -25.66M |
| Net Cash Per Share | -0.89 |
| Equity (Book Value) | -31.11M |
| Book Value Per Share | -1.22 |
| Working Capital | -18.82M |
Cash Flow
| Operating Cash Flow | -1.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 81.09%, with operating and profit margins of 0.91% and -25.99%.
| Gross Margin | 81.09% |
| Operating Margin | 0.91% |
| Pretax Margin | -25.99% |
| Profit Margin | -25.99% |
| EBITDA Margin | 0.95% |
| EBIT Margin | 0.91% |
| FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.65% |
| Shareholder Yield | -54.65% |
| Earnings Yield | -62.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -35.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.95 |
| Piotroski F-Score | 4 |